Axsome Therapeutics' subsidiary, Axsome Malta, entered into a License Agreement with Atnahs Pharma UK Limited, granting an exclusive license for the development and commercialization of Axsome's product Sunosi in Europe and certain countries in the Middle East and Africa, with upfront and milestone payments, as well as royalties on net sales.